![Erik M. Schwiebert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erik M. Schwiebert
Algemeen Directeur bij DiscoveryBioMed, Inc.
Profiel
Erik M.
Schwiebert is the founder.
He founded DiscoveryBioMed, Inc. in 2007 and currently holds the title of Chief Executive & Scientific Officer, Director.
Dr. Schwiebert's former job was as an Associate Professor at The University of Alabama.
Dr. Schwiebert's education includes a doctorate degree from Dartmouth College and an undergraduate degree from Grinnell College.
Actieve functies van Erik M. Schwiebert
Bedrijven | Functie | Begin |
---|---|---|
DiscoveryBioMed, Inc.
![]() DiscoveryBioMed, Inc. BiotechnologyHealth Technology DiscoveryBioMed, Inc. provides human cell-based drug discovery services. It provides pilot screening and high-throughput screening services for therapeutic-related bioassays, custom immortalized cell lines and therapeutics discovery for certain failure-to-secrete diseases in humans. The company was founded by Erik M. Schwiebert in October 2007 and is headquartered in Birmingham, AL. | Algemeen Directeur | 01-10-2007 |
Eerdere bekende functies van Erik M. Schwiebert
Bedrijven | Functie | Einde |
---|---|---|
The University of Alabama | Corporate Officer/Principal | - |
Opleiding van Erik M. Schwiebert
Dartmouth College | Doctorate Degree |
Grinnell College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
DiscoveryBioMed, Inc.
![]() DiscoveryBioMed, Inc. BiotechnologyHealth Technology DiscoveryBioMed, Inc. provides human cell-based drug discovery services. It provides pilot screening and high-throughput screening services for therapeutic-related bioassays, custom immortalized cell lines and therapeutics discovery for certain failure-to-secrete diseases in humans. The company was founded by Erik M. Schwiebert in October 2007 and is headquartered in Birmingham, AL. | Health Technology |